CareSignal (formerly Epharmix) offers interventions that use automated phone calls or text messages to manage patients’ conditions while collecting disease-specific data. Epharmix interventions align with value metrics and reimbursement opportunities.

For more information, visit CareSignal or follow their updates on:



  • $7.5m

CareSignal Articles

CareSignal Acquired by Lightbeam Health Solutions

Epharmix Rebrands To CareSignal

Epharmix Rebrands to CareSignal

CareSignal Raises $7M to Expand Nationally

St. Louis Startup Milestones Reached in 2018

It Takes a Village (and Universities Directly Engaging the Startup Ecosystem) to Retain Talent in St. Louis

Cultivation Capital EQ Life Science

Trends in Life Science and Healthcare Innovation


#CEO2CEO: Blake Marggraff of Epharmix and Anthony Tersigni of Ascension on Healthcare Technology

Epharmix Teams Up with Provident on Suicide Prevention Tools

Dollar sign fundraising

12 Fundraising Tips for BioTech Companies from Cultivation Capital’s Life Sciences Fund

Founder Series: Blake Marggraff of Epharmix

11 Washington University Companies That Have Made an Impact on STL’s Startup Scene

STL Entrepreneurs Impress at SXSW

Lewis & Clark Ventures Lead $9 Million Investment into Metro-East Startup OneSpace

Making Bold Moves

Startup Connection Announces 70 Companies In The 2015 Venture Showcase Lineup

Epharmix Raises $765,000, Farmplicity Launches New Platform